Adverum to build $82.8 milion facility in Durham County


California-based gene therapy company Adverum Biotechnologies will invest $82.8 million for a new gene therapy manufacturing facility in Durham County.

The investment will create more than 200 new jobs.

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. The company is developing its lead gene therapy candidate ADVM-022 in ongoing clinical trials for wet age-related macular degeneration and diabetic macular edema.

Adverum’s new presence in North Carolina will be facilitated, in part, by a Job Development Investment Grant approved by the state’s Economic Investment Committee.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.